U/S Whole Abdomen (DAO) at Dr. Essa Lab

Book at Dr. Essa Laboratories & Diagnostic Center · karachi

Book this test

Dr. Essa Laboratories & Diagnostic Center logo

Dr. Essa Laboratories & Diagnostic Center

30% off
Rs. 12,705Rs. 18,150

U/S Whole Abdomen (DAO) at Dr. Essa Lab

The U/S Whole Abdomen (DAO) at Dr. Essa Lab is a comprehensive, non-invasive diagnostic imaging procedure designed to evaluate the major organs and anatomical structures within the abdominal and pelvic cavities. Utilizing state-of-the-art high-frequency sound waves, this diagnostic modality allows clinical radiologists to visualize real-time structural details without exposing patients to ionizing radiation. The acronym DAO refers to a specialized diagnostic panel or administrative protocol established at Dr. Essa Lab, ensuring a standardized, thorough assessment of the abdominal viscera. This imaging study is highly valued in clinical medicine for its safety, efficacy, and rapid diagnostic yield, serving as a primary investigative tool for a wide spectrum of gastrointestinal, hepatobiliary, renal, and pelvic disorders.

The fundamental physics of ultrasound imaging rely on the transmission of high-frequency acoustic waves from a specialized transducer into the patient’s body. As these sound waves traverse different tissue interfaces, they encounter varying levels of acoustic impedance. A portion of the sound wave is reflected back to the transducer as an echo, while the remainder continues to travel deeper into the tissues. The transducer, utilizing the piezoelectric effect, converts these returning acoustic echoes into electrical signals, which are then processed by advanced computer software to generate detailed, real-time grayscale (B-mode) images. Additionally, color Doppler imaging can be integrated during the U/S Whole Abdomen (DAO) to assess vascular patency, blood flow velocity, and perfusion patterns within abdominal organs and suspected masses.

During a U/S Whole Abdomen (DAO) at Dr. Essa Lab, radiologists systematically evaluate several critical anatomical structures. In the upper abdomen, the liver is assessed for size, parenchymal echogenicity, surface contour, and focal lesions. The gallbladder and biliary tree are examined for the presence of calculi, wall thickening, or ductal dilatation. The pancreas is evaluated for inflammatory changes, calcifications, or mass lesions, although visualization can sometimes be limited by overlying bowel gas. The spleen is measured to rule out splenomegaly and inspected for parenchymal abnormalities. In the retroperitoneum, both kidneys are thoroughly imaged to assess their size, cortical thickness, corticomedullary differentiation, and to detect any calculi, cysts, tumors, or hydronephrosis. The abdominal aorta is also screened for aneurysmal dilation. In the lower abdomen and pelvis, the urinary bladder is evaluated for wall thickness, luminal masses, and post-void residual volume, while pelvic organs such as the uterus and ovaries in females, or the prostate gland in males, are assessed for structural abnormalities.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest diagnostic accuracy and image clarity during a U/S Whole Abdomen (DAO) at Dr. Essa Lab, patients must strictly adhere to specific preparation guidelines. These instructions are designed to minimize abdominal gas, which can reflect sound waves and obscure deep retroperitoneal structures, and to ensure optimal physiological conditions of the organs being evaluated.

  • Fasting Requirements: Patients must fast for a minimum of 6 to 8 hours prior to the scheduled examination. This means no food, solid or liquid, and no carbonated beverages. Fasting is absolutely critical because it prevents gallbladder contraction, allowing the organ to remain fully distended and filled with bile, which provides an excellent acoustic window for detecting gallstones, polyps, or wall thickening. Fasting also reduces the amount of swallowed air and peristaltic bowel gas that can block the visualization of the pancreas and abdominal aorta.
  • Hydration and Bladder Distension: For the pelvic portion of the whole abdomen ultrasound, a fully distended urinary bladder is required. Patients are instructed to drink approximately 4 to 5 glasses of water (about 1 liter) starting one hour before the procedure and to refrain from urinating until the scan is complete. A full bladder acts as an acoustic window, displacing gas-filled loops of bowel out of the pelvis and allowing the ultrasound waves to clearly reach and image the uterus, ovaries, prostate, and bladder walls.
  • Medications and Diet: Patients should continue taking their essential daily medications with small sips of plain water. On the day before the test, it is highly recommended to avoid gas-producing foods such as beans, cabbage, dairy products, and carbonated drinks to further optimize image quality.
  • Attire: Patients are advised to wear comfortable, loose-fitting, two-piece clothing to their appointment at Dr. Essa Lab. This allows easy access to the abdominal region without requiring a full change into a patient gown, although gowns are available if needed.

During the Procedure

The U/S Whole Abdomen (DAO) is a painless, safe, and relatively quick procedure that typically takes between 15 to 30 minutes to complete. The examination is performed by a highly qualified radiologist or a certified sonographer in a dedicated, dimly lit ultrasound suite at Dr. Essa Lab.

  • Positioning: The patient is asked to lie comfortably in a supine position (flat on their back) on an examination table. During the scan, the clinical professional may instruct the patient to turn onto their left or right side (lateral decubitus positions) to obtain better views of specific organs like the kidneys or spleen, or to assess the mobility of gallstones.
  • Application of Ultrasound Gel: A warm, water-soluble acoustic coupling gel is applied to the bare skin of the abdomen. This gel is essential because it eliminates any air pockets between the transducer and the skin surface, ensuring seamless transmission and reception of the high-frequency sound waves. The gel is hypoallergenic, non-staining, and easily wiped off after the procedure.
  • Scanning Process: The examiner gently presses the ultrasound transducer against the abdomen and moves it systematically across different quadrants. The patient may feel mild pressure as the transducer is swept over the skin, but this should not cause pain. If the abdomen is tender due to an underlying medical condition, some temporary discomfort may be experienced.
  • Breathing Instructions: To obtain clear, motion-free images, the radiologist will periodically ask the patient to take a deep breath and hold it for a few seconds. Deep inspiration pushes the diaphragm and abdominal organs downward, bringing them out from under the rib cage and making them highly visible to the ultrasound beam.
  • Safety and Comfort: Because ultrasound technology does not utilize ionizing radiation, there are no cumulative radiation risks, making it completely safe for all patients, including pregnant women and pediatric populations. The procedure is conducted with the utmost respect for patient privacy and comfort.

When is a U/S Whole Abdomen (DAO) Performed?

Evaluation of Persistent Abdominal Pain

Physicians frequently request a U/S Whole Abdomen (DAO) when a patient presents with acute, chronic, or recurrent abdominal pain of unexplained origin. The localization of pain often guides the ultrasound examination; for instance, right upper quadrant pain strongly suggests biliary pathology such as acute cholecystitis or biliary colic, while epigastric pain may point toward acute pancreatitis or hepatic disorders. Ultrasound allows the clinical team to rapidly evaluate these organs in real-time, identifying inflammatory changes, fluid collections, or structural abnormalities. By providing immediate visual evidence of organ pathology, the scan assists physicians in differentiating between conditions that require urgent surgical intervention and those that can be managed medically.

Investigation of Gastrointestinal and Hepatobiliary Symptoms

A U/S Whole Abdomen (DAO) is highly indicated for patients experiencing systemic or localized symptoms related to the digestive and hepatobiliary systems. These symptoms include unexplained nausea, persistent vomiting, abdominal bloating, early satiety, unexplained weight loss, and jaundice (yellowing of the skin and sclera). Jaundice often indicates an obstruction in the biliary system or underlying parenchymal liver disease. The ultrasound scan can quickly determine whether jaundice is obstructive (caused by gallstones or tumors blocking the bile ducts) or non-obstructive (related to hepatitis or cirrhosis). It also evaluates the liver parenchyma for fatty infiltration, diffuse changes, or focal masses, providing crucial diagnostic direction.

Assessment of Urinary Tract and Renal Function

When patients present with symptoms suggestive of renal or urological disorders, such as flank pain, hematuria (blood in the urine), dysuria (painful urination), recurrent urinary tract infections (UTIs), or abnormal kidney function tests (elevated blood urea or creatinine), a U/S Whole Abdomen (DAO) is an essential diagnostic step. The scan provides detailed anatomical views of both kidneys, allowing the radiologist to detect renal calculi, assess for hydronephrosis (swelling of the kidney due to urine backup), identify renal cysts or solid masses, and measure cortical thickness. Furthermore, by evaluating the urinary bladder, the test can identify bladder stones, wall thickening, or incomplete emptying, which are common causes of urinary symptoms.

Screening for Abdominal Masses and Organomegaly

During a routine physical examination, a healthcare provider may palpate an abnormal abdominal mass or suspect the enlargement of an internal organ, such as the liver (hepatomegaly) or spleen (splenomegaly). A U/S Whole Abdomen (DAO) is the gold standard imaging modality to confirm these clinical findings. The ultrasound can accurately measure the dimensions of the enlarged organs, characterize the nature of any palpable mass (determining whether it is cystic, solid, or complex), and evaluate its relationship with surrounding vascular structures and tissues. This screening capability is vital for the early detection of neoplastic processes, hematological disorders, or chronic congestive conditions.

Monitoring Known Conditions and Post-Surgical Follow-up

For patients with previously diagnosed chronic abdominal conditions, a U/S Whole Abdomen (DAO) serves as an invaluable tool for ongoing monitoring and surveillance. It is routinely used to track the progression of fatty liver disease, monitor the size and stability of known renal or hepatic cysts, and screen patients with liver cirrhosis for the development of portal hypertension or hepatocellular carcinoma. Additionally, this imaging study is performed post-operatively to evaluate the success of surgical interventions, check for postoperative fluid collections (such as abscesses, hematomas, or urinomas), and ensure the normal anatomical and functional recovery of the abdominal organs.

What Does a U/S Whole Abdomen (DAO) Detect?

A U/S Whole Abdomen (DAO) is a highly sensitive diagnostic tool capable of detecting a wide array of pathological conditions across multiple organ systems. In the hepatobiliary system, it readily identifies cholelithiasis (gallstones), choledocholithiasis (stones in the common bile duct), acute and chronic cholecystitis (gallbladder inflammation), gallbladder polyps, adenomyomatosis, and biliary ductal dilatation. Within the liver parenchyma, the scan detects hepatic steatosis (fatty liver disease), liver cirrhosis, portal hypertension (characterized by dilated portal veins and splenomegaly), hepatic cysts, hemangiomas, hepatic abscesses, and primary or metastatic liver tumors.

In the pancreas and spleen, the ultrasound can identify features of acute pancreatitis (such as diffuse pancreatic enlargement and peripancreatic fluid), chronic pancreatitis (calcifications and ductal dilation), pancreatic pseudocysts, pancreatic neoplasms, splenomegaly, splenic infarcts, and splenic cysts. For the renal and urological systems, the scan is highly effective in detecting nephrolithiasis (kidney stones), hydronephrosis, simple and complex renal cysts, polycystic kidney disease, renal cell carcinoma, angiomyolipomas, urinary bladder calculi, cystitis, bladder diverticula, and significant post-void residual urine volume.

Furthermore, the U/S Whole Abdomen (DAO) can detect free fluid within the peritoneal cavity (ascites), which may result from portal hypertension, malignancy, or peritonitis. It can also identify significant abdominal aortic aneurysms (AAA), retroperitoneal lymphadenopathy (enlarged lymph nodes), and inflammatory conditions of the bowel loops, such as acute appendicitis or diverticulitis, when clinical presentation warrants. In the pelvic region, the scan evaluates uterine fibroids, endometrial thickening, ovarian cysts, ovarian masses, and benign prostatic hyperplasia (BPH) in male patients, providing a comprehensive diagnostic overview of the entire abdominal and pelvic cavities.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that timely diagnostic results are crucial for effective clinical decision-making and patient peace of mind. The turnaround time for a U/S Whole Abdomen (DAO) report is highly optimized. In most cases, preliminary findings may be discussed with the patient immediately following the scan, while the finalized, comprehensive diagnostic report, meticulously reviewed and signed by a consultant radiologist, is typically available within a few hours of the procedure.

Dr. Essa Lab offers seamless and convenient access to diagnostic reports and imaging findings. Patients can access their reports online through the official Dr. Essa Lab web portal or dedicated mobile application by entering their unique patient registration credentials. Additionally, printed reports along with high-resolution diagnostic film prints or digital copies can be collected directly from the diagnostic center where the scan was performed. This efficient reporting system ensures that patients and their referring physicians receive accurate diagnostic data promptly, facilitating timely treatment planning.

U/S Whole Abdomen (DAO) Findings Overview

Structure / Parameter Evaluated Normal Findings Possible Abnormal Findings
Liver Normal size, homogeneous parenchymal echogenicity, smooth surface contour, normal caliber of hepatic and portal veins. Hepatomegaly, increased echogenicity (fatty liver), nodular surface (cirrhosis), focal lesions (cysts, hemangiomas, abscesses, tumors).
Gallbladder & Biliary Tree Anechoic lumen, wall thickness less than 3 mm, no internal calculi, normal common bile duct diameter (less than 6 mm). Cholelithiasis (gallstones), wall thickening (cholecystitis), sludge, polyps, dilated common bile duct (obstruction).
Spleen Homogeneous texture, longitudinal diameter less than 12-13 cm, normal vascularity. Splenomegaly (enlargement), focal splenic lesions, splenic cysts, subcapsular hematoma.
Pancreas Homogeneous echogenicity (iso- or hyperechoic to liver), normal caliber of pancreatic duct, no focal masses. Diffuse enlargement (acute pancreatitis), parenchymal calcifications (chronic pancreatitis), pseudocysts, pancreatic head/body/tail masses.
Kidneys Normal size, preserved cortical thickness, clear corticomedullary differentiation, no calculi or hydronephrosis. Nephrolithiasis (stones), hydronephrosis (pelvicalyceal dilation), renal cysts, solid renal masses, cortical thinning (chronic kidney disease).
Urinary Bladder Anechoic lumen, smooth and thin wall (less than 4 mm when distended), complete emptying post-voiding. Bladder calculi, wall thickening (cystitis/outlet obstruction), bladder masses, significant post-void residual volume.
Abdominal Aorta Normal caliber, diameter less than 3 cm, smooth parallel walls, no thrombus. Aortic ectasia, abdominal aortic aneurysm (AAA), mural thrombus, calcified atherosclerotic plaques.
Pelvic Organs (Uterus/Ovaries/Prostate) Normal uterine size and endometrial thickness, normal ovarian volume and follicular activity, normal prostate volume (less than 25-30 cc). Uterine fibroids, endometrial hyperplasia, ovarian cysts or adnexal masses, benign prostatic hyperplasia (BPH), pelvic free fluid.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for U/S Whole Abdomen (DAO)?

  • Experienced Healthcare Professionals: Dr. Essa Lab features a team of highly qualified consultant radiologists and certified sonographers with extensive clinical experience in abdominal imaging.
  • Patient-Focused Care: Every patient is treated with utmost empathy, dignity, and personalized attention, ensuring a comfortable and stress-free diagnostic experience.
  • Quality Diagnostic Services: Adhering to strict international quality control standards, Dr. Essa Lab delivers highly accurate and reliable diagnostic imaging results.
  • Professional Reporting: Diagnostic reports are meticulously structured, detailed, and verified by expert radiologists to provide clear clinical guidance to referring physicians.
  • Modern Diagnostic Approach: Utilizing advanced diagnostic methodologies and standardized imaging protocols, Dr. Essa Lab ensures comprehensive evaluation of all abdominal structures.
  • Comfortable Environment: The diagnostic centers are designed to provide a clean, hygienic, and welcoming atmosphere, prioritizing patient safety and comfort.
  • Convenient Location: With multiple branches strategically located across Karachi, patients can easily access high-quality diagnostic services close to home.
  • Commitment to Accurate Diagnosis: Dr. Essa Lab is dedicated to maintaining the highest levels of diagnostic precision, utilizing state-of-the-art ultrasound technology to support clinical decision-making.

Frequently Asked Questions